fibrositis

(redirected from fibromyalgia)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to fibromyalgia: rheumatoid arthritis, Lupus

fibrositis

inflammation of white fibrous tissue, esp that of muscle sheaths

fibrositis

[‚fī·brə′sīd·əs]
(medicine)
Inflammation of white fibrous connective tissue, usually in a joint region.
Mentioned in ?
References in periodicals archive ?
The FM/a Test, the first fibromyalgia blood test to comply with US Food and Drug Administration standards, diagnoses fibromyalgia by identifying the presence of specific white blood cell abnormalities that have been documented to exist in these patients.
There is a theory that fibromyalgia may be linked to a virus that also may be responsible for chronic fatigue syndrome; however, the specific etiology is still unknown.
Brady as an experienced leader in the field of functional medicine has created a program to help patients fix their fibromyalgia.
Instead, the findings open the door to evaluating the effects of dextromethorphan on fibromyalgia and other conditions marked by heightened pain sensitivity, according to Staud, an associate professor of medicine at the University of Florida in Gainesville.
This was a typical population of fibromyalgia patients: 93% were women, 94% white, with a mean age of 50 years.
While drug treatments absolutely continue to play a role in the management of fibromyalgia, the long-term safety and efficacy of nonpharmacologic treatments should be appreciated and stressed," he said.
The Israeli approach is different in that it is not based upon the initial severity of fibromyalgia.
Three other, independent research groups have recently made similar findings of small-nerve deficits in the skin of fibromyalgia patients, including researchers at Massachusetts General Hospital in Boston (Pain 2013;154:2310-6), further boosting the likelihood that impaired small-nerve function is real and a key feature of at least some fibromyalgia patients, Dr.
Fibromyalgia, or Fibromyalgia Syndrome (FMS), is not a new condition.
Patients with fibromyalgia have been found to have elevated levels of substance P in their spinal fluid, a chemical that helps transmit pain signals from the brain.
In conjunction with launching the CARE & Make Fibromyalgia Visible campaign the NFMCPA held a successful Leaders Against Pain (LAP) training meeting last November in Washington, DC, where twenty new LAP were educated in creating a fibromyalgia event and how to promote it to local, state and national media.